US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Kesla A (0EYY) 銘柄情報

Kesla A (0EYY)

4.35

0.00

(0.00%)

終了 7月13日 12:30AM

Kesla A (0EYY) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

4.35

( - )

買値

4.14

売値

4.56

出来高

400

平均取引量 (3 か月)

21,078 €

財務取引量

-

0.00 日の範囲 0.00

4.35 52 週間の範囲 4.35

時価総額

企業価値

26.153M

前日終値

4.35

始値

-

時刻

最終取引時間

VWAP

-

歳入

34.41M

純利益

-4.46M

発行済株式数

3,370,898

浮動株比率 (%)

38.79%

機関投資家保有比率 (%)

11.98%

配当利回り

PER

-3.49

株価売上高倍率 (PSR)

0.45

1 株当たり利益 (EPS)

-1.32

ベータ

0.22

Kesla Oyj develops machinery, technology, and services for customers in the forest and other industries in Finland. The company offers truck and stationary cranes, including timber and city cranes, and truck and industrial cranes, harvester heads, and forest machine cranes. It also provides tractor ... Kesla Oyj develops machinery, technology, and services for customers in the forest and other industries in Finland. The company offers truck and stationary cranes, including timber and city cranes, and truck and industrial cranes, harvester heads, and forest machine cranes. It also provides tractor equipment, including loaders, forestry trailers, multi-purpose trolleys, trailers, heart rate processor, and grapples. The company was founded in 1960 and is headquartered in Joensuu, Finland. 詳細を表示

セクター

Industrials

業界

Machinery

ウェブサイト

www.kesla.fi

本社

Joensuu, Finland

設立

1960

Kesla A is listed in the Industrials sector of the ロンドン証券取引所 with ticker 0EYY. The last closing price for Kesla A was 4.35 €. Over the last year, Kesla A shares have traded in a share price range of 4.35 € to 4.35 €.

Kesla A currently has 3,370,898 shares in issue. The market capitalisation of Kesla A is 14.66 € million. Kesla A has a price to earnings ratio (PE ratio) of -3.49.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	4.35	4.35	4.35	82	4.35	DE
52	0	0	4.35	4.35	4.35	120	4.35	DE
156	0	0	4.35	4.35	4.35	54	4.35	DE
260	0	0	4.35	4.35	4.35	31	4.35	DE

0EYY - Frequently Asked Questions (FAQ)

What is the current Kesla A share price?

The current share price of Kesla A is 4.35 €

How many Kesla A shares are in issue?

Kesla A has 3,370,898 shares in issue

What is the market cap of Kesla A?

The market capitalisation of Kesla A is EUR 14.66M

What is the 1 year trading range for Kesla A share price?

Kesla A has traded in the range of 4.35 € to 4.35 € during the past year

What is the PE ratio of Kesla A?

The price to earnings ratio of Kesla A is -3.49

What is the cash to sales ratio of Kesla A?

The cash to sales ratio of Kesla A is 0.45

What is the registered address of Kesla A?

The registered address for Kesla A is Kuurnankatu 24, Joensuu, North Karelia, 80100

What is the Kesla A website address?

The website address for Kesla A is www.kesla.fi

Which industry sector does Kesla A operate in?

Kesla A operates in the Machinery sector

FDA-agent-2

FDA-agent-2 5分前

You have to wonder why Shanjan Dr. is stil following a stock that has been delisted for over two years from the stock market.? he is either has a vested interest in the molecule Lenzi or/and works for Taran. Either way it doesn't matter.nobody would be wastin their time arguing whether a drug or mol

ipiros

4 plus years for me also brother, hope you are wrong but might be right.

urge2surge

urge2surge 6分前

Past will be prologue. Expecting anything other than dilution and flip opportunities, especially given the evidences of negative roi, is discarding all past events and actions.
Takes two sides to make a market but it also takes a big step back to be objective. Could go either way here but r

US Market News

US Market News 7分前

KKR Leads A$400 Million Financing Solution for AmpolJuly 12, 2026 6:34 PM
Business Wire KKR, a leading global investment firm, today announced its cornerstone investment in a A$400 million (US$275 million) financing solution (the "Financing") for Ampol Limited (ASX: ALD) ("Ampo

VapeGod3000

VapeGod3000 8分前

How are people not connecting the dots here? $ATWT is literally spilling the beans right in front of us. Sharebuy back program plus awarded contracts being announced soon. The timing and location of this can’t be anymore clear if you are paying attention

https://canada.constructconne

ron_66271

ron_66271 8分前

Yes FDIC is Using WMB Notes as a Lien against WMI Property.

JPM needs to complete the purchase of WMB and close out the WMB Notes. The WMB Notes are backed up by ~$26 Billion in securities that covers the ~$14.7 Billion claim.

This game needs to end!!
?$#*•=.

nicehit

nicehit 10分前

Just more lies from the nut case crowd!

Pittkid

Pittkid 11分前

100lbStriper

100lbStriper 12分前

and the day it happens all will be forgiven!!!

xodcode

xodcode 14分前

Well, like ambulance chasers, you try to create the worst possible scenario, when you have no evidence to support your worst case scenario.

By the way, TGD? remains on the board of directors which suggests that perhaps the sky isn't falling as your excessive efforts try to portray.

eastunder

eastunder 15分前

Earnings Start 7-8-26

NFLX 7-16 A

T 7-22 B 2Q
TSLA 7-22 A
NOW 7-22 A
GOOGL 7-22 A
RNG 7-23 A
INTC 7-23 A

CTSH 7-29 B
CMG 7-29 A
QCOM 7-29 A

AAPL 7-30 A
RIVN 7-30 A

AMD 8

Kjv

I did a comparison of FITY’s bio in the last 3 PRs The lastest one shows an addition of “potential acquisitions and commercialization pathways “ those were deliberately added.
I always say in OTC, you buy and gamble on speculative moves and by the time the moves start taking shape …not gonna

SmallCaps55

SmallCaps55 21分前

Why would they increase the A/S to 750 million shares? How can they possibly need that many common shares now that the bid/ask is at $3/share. That would be over $2B market cap at 3 bucks. Management being greedy. They should have R/S the allowable shares too.

blownaccount9

blownaccount9 22分前

Are you really pretending you have a press connection? 😂 would you have been here the last decade if this was true?

Golden Cross

Golden Cross 23分前

All shareholders spread the word about your stock... You will get called a pumper for spreading AABB company information but who cares...

Insidia

Insidia 23分前

What happened to their previous "strategic partnership" with AIG?

BIOChecker4

BIOChecker4 25分前

Ambulance chasers are injury lawyers looking to extract as much money as possible for their clients who are most often laid up with serious injuries in a hospital bed. How exactly am I being an ambulance chaser?

The comment you were reacting to is that I think the situation at Anavex

Jetmek_03052

Jetmek_03052 26分前

Please. Stop spoofing the board.

Looking forward to the filing this week. Expecting some positive results in it!

When someone says that, it's usually expected that they have sound reasoning for such "expectations".

Tell the board - what are you seeing i

Eli's Gone

Eli's Gone 29分前

Field: JUL 16 - 19 The Open Championship Royal Birkdale Golf Club Southport • England FedexCup 750 pts

https://www.pgatour.com/tournaments/2026/the-open-championship/R2026100

https://www.theopen.com/field

Eli's Gone

Eli's Gone 31分前

2026 Diehard standings Segment 3 Event 5 of 12---Event 25 of 32 overall:

Segment 3 events

***NOTE*** Event 6 is across the pond this week....event tees off early Thurs morning

https://investorshub.advfn.com/uimage/uploads/2026/6/7/sbmfnevents_header.jpg

ErnieBilco

ErnieBilco 33分前

EF - You read mine correctly but to be fair I don't have nearly the positions you all are holding, Deep down I'm hoping to be proven wrong bigly wrong.

It's just a wait and see at this point

Latenightmike57

Latenightmike57 36分前

zakattack

zakattack 36分前

you make up lies and stories nothing is true with you 4 years of nothing and now you say major players why dno't you actually prove what you say for once instead of just pretending to fantasy

Guido2

Guido2 36分前

https://x.com/GuidoPerei/status/2076429841717657604?s=20

LTListener

LTListener 37分前

One of the things you need to consider is older ampakines from my novice research generally had short half life, lesser efficacy and beset with higher side effects in high impact ampakines. So development paths are narrow for those.

I believe the newer ampakines like CX717, CX1739 ad

Flapper TEC PNA PNB

Goldman Sachs Future Hea...

Oryzon Genomics

iShares iBonds Dec 2028 ...

Toho Acetylene (PK)

Ipopema Securities

SD Standard ETC

Zoom Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。